Targeting Participants for Adult Drug Courts Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals.

Slides:



Advertisements
Similar presentations
Criminal Justice and Behavioral Health Partnerships Review of projects recognizing the needs of and providing treatment supports to DUI offenders Nisha.
Advertisements

Integrating Risk/Needs Assessment Into Drug Court
Treatment of Substance Involved Offenders in Criminal Justice Settings – Challenges & Outcomes Igor Koutsenok, MD, MS Assistant Professor of Psychiatry,
Best Practices Standards Vol. I: An Overview. OBJECTIVES  Define Best Practices Standards  Identify the need for Best Practices Standards  Briefly.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Effective Strategies for Drug-Abusing.
Evidence Best Practices & Latest Research Presented by: Dr. Cary Heck University of Wyoming National Association of Drug Court Professionals Developed.
Practical Application of the ORAS The Corrections Institute Center for Criminal Justice Research University of Cincinnati.
Working with Young Adults years old
Community-Oriented Defense Performance Indicators A Conceptual Overview Michael Rempel Center for Court Innovation Presented at the Community-Oriented.
Drug Courts: Some Answers to Our Burning Questions NADCP May 2008 How Drug Court Practices Impact Recidivism and Costs Shannon Carey, Ph.D. August 2014.
West Virginia’s Drug Courts: An Overview Division of Probation Services,
May 1, Division of Parole and Probation Tony DeCrona, Interim Chief Kim Madris, Deputy Chief Tony DeCrona, Interim Chief Kim Madris, Deputy Chief.
Childhood Violence Exposure and the Behavioral Health/Juvenile Justice Initiative Jeff Kretschmar, Ph.D. Begun Center for Violence Prevention Research.
Targeting Dispositions by Risk, Need, Responsivity Modeling If / Then Decisions Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals.
Findings from a Dual Generic and Specific Risk Assessment Process for Domestic Violence Perpetrators in Connecticut Kirk R. Williams, Ph.D. Professor of.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania Effective Use of Rewards & Sanctions.
Center for Advancing Correctional Excellence, ACE! Department of Criminology, Law & Society George Mason University Amy Murphy, MPP Faye Taxman, Ph.D.
ASSESSMENTS OF JUVENILE OFFENDERS THROUGH EVIDENCE-BASED PRACTICES
DIVISION OF JUVENILE JUSTICE: WHAT WE DO AND HOW WE’RE DOING. March 10, 2014 Anchorage Youth Development Coalition JPO Lee Post.
JFA Associates/The Institute, Washington, DC/Austin, Texas Risk Assessment Facts, Myths and Trends James Austin, Ph.D
Different Pathways To Offending and Violence: An Examination Of The Differences Among Youths With Varying Histories Of Contact With The Juvenile Justice.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Effective Use of Rewards & Sanctions.
Drug Court ♦The alternative to incarceration  History žHow and why the experiment evolved  Main Features of Drug Court žCooperation within the adversarial.
Key Moments in NADCP History A DULT D RUG C OURT A DULT D RUG C OURT B EST P RACTICE S TANDARDS B EST P RACTICE S TANDARDS D OUGLAS B. M ARLOWE, J.D.,
Assessment of Risk and Need
Evidence-Based Sentencing. Learning Objectives Describe the three principles of evidence- based practice and the key elements of evidence-based sentencing;
Mayor’s Office of Homeland Security and Public Safety Gang Reduction Program Los Angeles.
Offender Rehabilitation
Working with Young Adults years old
Juvenile Crime Prevention Evaluation Phase 2 Interim Report Findings in Brief Juvenile Crime Prevention Evaluation Phase 2 Interim Report Findings in Brief.
Presented by: Cary Heck, Ph.D. University of Wyoming
Risk/Needs Assessment Within the Criminal Justice System.
Integrating Offender Screening Process into Specialty Court Eligibility Determination Presenter: Steven Fritz, LPC, LADC Clinical Director, Human Skills.
Douglas B. Marlowe, J.D., Ph.D.
TREATMENT COURTS Inns of Court Presentation By John Markson & Elliott Levine October 17, 2012.
Treatment is the Key: Addressing Drug Abuse in Criminal Justice Settings Redonna K. Chandler, Ph.D. Branch Chief Services Research Branch Division of Epidemiology,
RISK AND NEED TRACKS SAMHSA 2013 Orleans Parish Drug Court Expansion Grant.
Key Moments in NADCP History B EST P RACTICES IN J UVENILE D RUG C OURTS B EST P RACTICES IN J UVENILE D RUG C OURTS D OUGLAS B. M ARLOWE, J.D., P H.D.
Assessment of Alcohol-Involved Offenders Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals Treatment Research Institute.
What Makes Drug Courts Effective? Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction.
Targeting Participants for Drug Courts Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Effective Programs for Drug Offenders.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania Evidence-Based Dispositions for Drug Offenders.
National Center for Youth in Custody First Things First: Risk and Needs Assessment Data to Determine Placement and Services Alternatives.
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Targeting Dispositions by Risks &
Drug Related Issues Questions and Curiosities?. Looking at SAMHSA Site Observations? What does this site tell you about the government’s priorities, agenda,
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Targeting Dispositions by Risks &
Cedar Mountain Center Trends and Developments in Substance Abuse Treatment Kim Fletcher Marketing Director.
Immediate Sanction Probation Pilot Project Virginia Criminal Sentencing Commission June 8, 2015.
Judge Neil Edward Axel District Court of Maryland (retired) Maryland Highway Safety Judicial Conference December 2, 2015 Best Practices & Sentencing Alternatives.
Brain diseases: Substance abuse and co-occurring disorders Mark Publicker, MD FASAM.
CLASSIFICATION Risk Institutional violence/misconduct Institutional violence/misconduct Suicide Suicide Recidivism Recidivism A standardized assessment.
Targeting Participants for Drug Courts Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals.
Improving Outcomes for Young Adults in the Justice System Challenges and Opportunities.
Reducing Recidivism and Promoting Recovery: Implications of National and State Trends for Improving Treatment Programs Alexa Eggleston, J.D. Program Director,
Liam Ennis, Ph.D., R.Psych INTEGRATED THREAT AND RISK ASSESSMENT CENTRE/ ALBERTA LAW ENFORCEMENT RESPONSE TEAMS Using the Principles of Risk, Need, and.
Principles of Drug Abuse Treatment for Criminal Justice Populations Janelle Prueter Illinois TASC Presented to RSAT West VA Conference July 21, 2011.
Performance Evaluation of Drug Courts Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction.
Department of Sociology & Criminal Justice Research Questions To what extent is family support related to reoffending for individuals recently released.
Promising Practices in Criminal Justice Reform
A MULTI-TRACK DUI COURT SYSTEM FOR REPEAT OFFENDERS
Using Observation to Enhance Supervision CIMH Symposium Supervisor Track Oakland, California April 27, 2012.
What works and What Doesn’t in Reducing Recidivism: Some Lessons Learned from Evaluating Correctional Programs By: Edward Latessa School of Criminal Justice.
Chapter 4 Probation: How Most Offenders Are Punished
Sarah L. Desmarais, Ph.D. North Carolina State University
Community Corrections Alternative Program
Douglas B. Marlowe, J.D., Ph.D., FCPP
Evidence-Based Criminal Justice Reform
Annals of Research and Knowledge (ARK)
Presentation transcript:

Targeting Participants for Adult Drug Courts Douglas B. Marlowe, J.D., Ph.D. National Association of Drug Court Professionals

CitationInstitution(s) No. Drug Courts Crime Reduced Wilson et al. (2006) CampbellCollaborative 55 14% Latimer et al. (2006) Canada Dept. of Justice 66 9% 9% Shaffer (2010) University of Nevada 76 9% 9% Lowenkamp et al. (2005) University of Cincinnati 22 8% 8% Aos et al. (2006) Washington State Inst. for Public Policy for Public Policy 57 Mitchell et al. (2012) U.S.F., G.M.U. & Penn. State 92 12% Avg. Crime Reduction Rempel et al. (2012) Urban Institute, CCI & RTI 23 13%

Variable Effects (Carey et al., 2012; Downey & Roman, 2010; GAO, 2011; Mitchell et al., 2012; Shaffer, 2010)

72% - 88% 6%-9% 8% - 16% Most drug courts work Variable Effects (Carey et al., 2012; Downey & Roman, 2010; GAO, 2011; Mitchell et al., 2012; Shaffer, 2010) Some don’t work Some are harmful Let’s do the math: 2,559 drug courts (as of 12/31/10) 2,559 drug courts (as of 12/31/10) x.06 = 154 harmful drug courts + another 205 ineffective drug courts + another 205 ineffective drug courts

Variable Cost Benefits (Downey & Roman, 2010) ~71% ~ 15% 14% 14% cost beneficial “[M]ost of the crimes prevented are insignificant in nature. Collectively, theft, drug offenses, trespassing, and traffic offenses make up over 60% of the comparison group’s arrests. These crimes are nearly costless to society, and so in terms of reduced victimization, preventing these crimes contributes little.” “[M]ost of the crimes prevented are insignificant in nature. Collectively, theft, drug offenses, trespassing, and traffic offenses make up over 60% of the comparison group’s arrests. These crimes are nearly costless to society, and so in terms of reduced victimization, preventing these crimes contributes little.” (pp )

Effect Size by Risk Level Percent reduction in rearrests 5% 10%* Lowenkamp et al., 2005 Twice the reduction in rearrests } 8% *p <.05 “Moderator analysis”

Drug Courts That Accepted Participants With Non- Drug Charges Had Nearly Twice the Reduction in Recidivism *p <.05 Non-drug charges included property, theft, prostitution and forgery offenses Carey et al. (2012)

Drug Courts That Accepted Participants With Prior Violence Had Equivalent Reductions in Recidivism p = n.s. Carey et al. (2012)

Drug Courts That Excluded Participants with Serious Mental Health Problems Had Over 50% Less Cost Savings *p <.05 Carey et al. (2012)

Avg. Benefit Per $1 invested Benefit /cost dollar ratio $2.21 $2.15 $4.13 $3.36 ~ 50% greater cost benefits } Bhati et al. (2008) “Synthetic analysis” { ~ 90% greater cost benefits

Risk Principle Not necessarily a risk for violence or dangerousnessNot necessarily a risk for violence or dangerousness Risk essentially means a complicated prognosis or lesser amenability to treatmentRisk essentially means a complicated prognosis or lesser amenability to treatment The higher the risk level, the more intensive the supervision and accountability should be; and vice versaThe higher the risk level, the more intensive the supervision and accountability should be; and vice versa Mixing risk levels is contraindicatedMixing risk levels is contraindicated (Andrews & Bonta, 2010)

Prevalent Risk Factors Current age < 25 yearsCurrent age < 25 years Delinquency onset < 16 yearsDelinquency onset < 16 years Substance abuse onset < 14 yearsSubstance abuse onset < 14 years Prior convictionsPrior convictions Prior rehabilitation failuresPrior rehabilitation failures History of violenceHistory of violence Antisocial personality disorder or psychopathyAntisocial personality disorder or psychopathy Familial history of crime or addictionFamilial history of crime or addiction Criminal or substance abuse associationsCriminal or substance abuse associations

Need Principle Target criminogenic needs, not all needsTarget criminogenic needs, not all needs –Responsivity: Treat disorders or functional impairments that may be lesser predictors of recidivism, but complicate risk reduction The higher the need level, the more intensive the treatment or rehabilitation services should be; and vice versaThe higher the need level, the more intensive the treatment or rehabilitation services should be; and vice versa Mixing need levels is contraindicatedMixing need levels is contraindicated (Andrews & Bonta, 2010)

Substance Dependence or Addiction Substance Dependence or Addiction Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms } Abstinence is a distal goal Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms Substance Abuse } Abstinence is a distal goal Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms Substance Abuse } Abstinence is a distal goal Abstinence is a proximal goal } Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms Substance Abuse Collateral needs Collateral needs –Dual diagnosis –Serious functional impairments } Abstinence is a distal goal Abstinence is a proximal goal } Criminogenic Needs

Substance Dependence or Addiction Substance Dependence or Addiction 1.Triggered binge response 2.Cravings or compulsions 3.Withdrawal symptoms Substance Abuse Collateral needs Collateral needs –Dual diagnosis –Serious functional impairments } Abstinence is a distal goal Abstinence is a proximal goal } } Regimen compliance is proximal Criminogenic Needs

Risk & Needs Matrix High Risk Low Risk HighNeeds(dependent) LowNeeds(abuse) Accountability, Treatment & Habilitation Treatment&Habilitation Accountability&Habilitation Diversion & Secondary Prevention

Practice Implications High Risk Low Risk HighNeeds(dependent) LowNeeds(abuse) Status calendar Status calendar Treatment (~200 hrs.) Treatment (~200 hrs.) Prosocial & adaptive habilit. Prosocial & adaptive habilit. Graduated consequences Graduated consequences for substance use for substance use Positive reinforcement Positive reinforcement Self-help/alumni groups Self-help/alumni groups Noncompliance calendar Noncompliance calendar Treatment (separate milieu) Treatment (separate milieu) Adaptive habilitation Adaptive habilitation Graduated consequences Graduated consequences for substance use for substance use Positive reinforcement Positive reinforcement Self-help/alumni groups Self-help/alumni groups Status calendar Status calendar Prosocial habilitation Prosocial habilitation Substantial consequences Substantial consequences for substance use for substance use Negative reinforcement Negative reinforcement Noncompliance calendar Noncompliance calendar Psycho-education Psycho-education “Zero tolerance” for “Zero tolerance” for substance use substance use Individual/stratified groups Individual/stratified groups Shorter supervision period Shorter supervision period

Assessment is Key Structured assessments are far superior to professional judgmentStructured assessments are far superior to professional judgment –No suitability determinations Tools are validated and culturally unbiasedTools are validated and culturally unbiased Administered prior to entry of conditionsAdministered prior to entry of conditions Many risk tools are adequateMany risk tools are adequate Most clinical tools are not adequate for identifying the target population for Drug CourtsMost clinical tools are not adequate for identifying the target population for Drug Courts –structured DSM-congruent diagnostic interview –assessors trained on criteria and item intent –check records and interview collaterals

Summary Drug courts reduce re-arrest rates approximately twice as much for high-risk participants than for low-risk participantsDrug courts reduce re-arrest rates approximately twice as much for high-risk participants than for low-risk participants Drug courts are approximately 50% more cost- effective for high-risk participants than for low- risk participantsDrug courts are approximately 50% more cost- effective for high-risk participants than for low- risk participants Removing eligibility restrictions helps to reach the target populationRemoving eligibility restrictions helps to reach the target population

Recommendations 1.Remove unwarranted eligibility restrictions based on criminal history and clinical severity 2.Target high-risk and high-need participants using standardized and validated assessments 3.Cease suitability determinations based on motivation, attitude, or readiness for change 4.Do not mix risk or need levels in your milieu 5.If necessary, develop alternate tracks based on risk and/or need